Ligand validation:5OT9

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5OT9_EDO_A_301	39%	84%	0.151	0.856	0.7	0.09	-	-	0	0	100%	1
5OT9_EDO_A_304	32%	84%	0.14	0.813	0.69	0.09	-	-	0	0	100%	1
5OT9_EDO_A_305	21%	87%	0.211	0.817	0.71	0.01	-	-	0	0	100%	1
5OT9_EDO_A_302	21%	78%	0.252	0.859	0.59	0.3	-	-	0	0	100%	1
5OT9_EDO_A_306	3%	81%	0.234	0.568	0.64	0.19	-	-	0	0	100%	1
5OVZ_EDO_A_305	51%	78%	0.145	0.899	0.71	0.21	-	-	0	0	100%	1
4POW_EDO_A_304	30%	82%	0.177	0.841	0.53	0.28	-	-	0	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1
3G7R_EDO_B_961	100%	85%	0.035	0.988	0.45	0.3	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.